Lockhart, A. C., Bauer, T. M., Aggarwal, C., Lee, C. B., Harvey, R. D., Cohen, R. B., . . . Dowlati, A. (2018). Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors. Invest New Drugs.
Citação norma ChicagoLockhart, A Craig, et al. "Phase Ib Study of Pevonedistat, a NEDD8-activating Enzyme Inhibitor, in Combination With Docetaxel, Carboplatin and Paclitaxel, or Gemcitabine, in Patients With Advanced Solid Tumors." Invest New Drugs 2018.
Citação norma MLALockhart, A Craig, et al. "Phase Ib Study of Pevonedistat, a NEDD8-activating Enzyme Inhibitor, in Combination With Docetaxel, Carboplatin and Paclitaxel, or Gemcitabine, in Patients With Advanced Solid Tumors." Invest New Drugs 2018.